Treatment outcome and laboratory confirmation of tuberculosis diagnosis in patients with HIV/AIDS in Recife, Brazil;Desfecho do tratamento e confirmação laboratorial do diagnóstico de tuberculose em pacientes com HIV/AIDS no Recife, Pernambuco, Brasil

Jornal Brasileiro de Pneumologia

Volumn 34, Issue 6, 2008, Pages 394-403

  Maruza, Magda ^a,c   Ximenes, Ricardo Arraes De Alencar ^b   Lacerda, Heloísa Ramos ^b  

^a Hospital Correia Picanço Secretaria de Saúde   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c NONE   (Brazil)

Author keywords

Diagnosis; HIV infections; Therapeutics; Treatment outcome; Tuberculosis

Indexed keywords

ADULT; AIDS RELATED COMPLEX; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; EPIDEMIOLOGY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; MORTALITY; PATIENT; STATISTICS; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BRAZIL; CD4 LYMPHOCYTE COUNT; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT DROPOUTS; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS; VIRAL LOAD;

EID: 47649086860     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/S1806-37132008000600010     Document Type: Article

References (30)

1. Kramer F, Modilevsky T, Waliany AR, Leedom JM, Barnes PF. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med. 1990;89(4):451-6.
2. De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA. 1992;268(12):1581-7.
3. Alpert PL, Munsiff SS, Gourevitch MN, Greenberg B, Klein RS. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis. 1997;24(4):661-8.
4. Ritacco V, Di Lonardo M, Reniero A, Ambroggi M, Barrera L, Dambrosi A, et al. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis. 1997;176(3):637-42.
5. American Thoracic Society; CDC; Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52(RR-11):1-77. Erratum in: MMWR Recomm Rep. 2005;53(51):1203.
6. Kang'ombe C, Harries AD, Banda H, Nyangulu DS, Whitty CJ, Salaniponi FM, et al. High mortality rates in tuberculosis patients in Zomba Hospital, Malawi, during 32 months of follow-up. Trans R Soc Trop Med Hyg. 2000;94(3):305-9.
7. Harries AD, Nyangulu DS, Kang'ombe C, Ndalama D, Glynn JR, Banda H, et al. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi. Trans R Soc Trop Med Hyg. 1998;92(3):343-7.
8. Apers L, Wijarajah C, Mutsvangwa J, Chigara N, Mason P, van der Stuyft P. Accuracy of routine diagnosis of pulmonary tuberculosis in an area of high HIV prevalence. Int J Tuberc Lung Dis. 2004;8(8):945-51.
9. Murray J, Sonnenberg P, Shearer SC, Godfrey-Faussett P. Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med. 1999;159(3):733-40.
10. Diniz LS, Gerhardt G, Miranda JA, Manceau JN. Efetividade do tratamento da tuberculose em 22 municípios de capitais brasileiras e Distrito Federal. Bol Pneumol Sanit. 2003;11(1):5-14.
11. Klein NC, Duncanson FP, Lenox TH 3rd, Pitta A, Cohen SC, Wormser GP. Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest. 1989;95(6):1190-2.
12. Mohammad Z, Naing NN. Characteristics of HIV-infected tuberculosis patients in Kota Bharu Hospital, Kelantan from 1998 to 2001. Southeast Asian J Trop Med Public Health. 2004;35(1):140-3.
13. Oliveira HB, Marin-León L, Gardinali J. Analysis of treatment outcomes related to the tuberculosis control program in the city of Campinas, in the state of São Paulo, Brazil. J Bras Pneumol 2005;31(2):133-8.
14. Hopewell PC. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis. 1992;15(3):540-7.
15. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA. 1995;273(3):220-6.
16. Anglaret X, Saba J, Perronne C, Lacassin F, Longuet P, Leport C, et al. Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis. Tuber Lung Dis. 1994;75(5):334-40.
17. Ruiz-Navarro MD, Espinosa JA, Hernández MJ, Franco AD, Carrillo CC, García AD, et al. [Effects of HIV status and other variables on the outcome of tuberculosis treatment in Spain][Article in Spanish]. Arch Bronconeumol. 2005;41(7):363-70.
18. Lima MB, Mello DA, Morais APA, Silva WC. Estudo de casos sobre o abandono do tratamento da tuberculose: avaliação do atendimento, percepção e conhecimentos sobre a doença na perspectiva dos clientes (Fortaleza, Ceará, Brasil). Cad Saúde Pública. 2001;17(4):877-85.
19. Hongthiamthong P, Riantawan P, Subhannachart P, Fuangtong P. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre. J Med Assoc Thai. 1994;77(10):520-5.
20. Brito AM, Castilho EA, Szwarcwald CL. Regional patterns of the temporal evolution of the AIDS epidemic in Brazil following the introduction of antiretroviral therapy. Braz J Infect Dis. 2005;9(1):9-19.
21. Ackah AN, Coulibaly D, Digbeu H, Diallo K, Vetter KM, Coulibaly IM, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet. 1995;345(8950):607-10.
22. Whalen C, Okwera A, Johnson J, Vjecha M, Hom D, Wallis R, et al. Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration. Am J Respir Crit Care Med. 1996;153(6 Pt 1):1977-81.
23. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1376-95.
24. Kritski AL, Conde MB, Souza GRM. Tuberculose: do ambulatório à enfermaria. 2nd ed. São Paulo: Atheneu, 2000.
25. Rocha M, Pereira S, Ferreira L, Barros H. The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen. Eur Respir J. 2003;21(5):785-8.
26. Burman WJ, Jones BE. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med. 2001;164(1):7-12.
27. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998;158(1):157-61.
28. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids. Recomendações para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV. Brasília: Ministério da Saúde, 2004.
29. Dheda K, Lampe FC, Johnson MA, Lipman MC. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis. 2004;190(9):1670-6.
30. Belmiro VM, Neves DD, Carvalho SR. [Tuberculosis profile in HIV+ patient before and after the use of high activity antiretroviral treatment] [Article in Portuguese]. Rev Port Pneumol. 2004;10(3):205-15.